ArticleCanadian journal of kidney health and disease2017
Validation of the Kidney Failure Risk Equation in Manitoba.
Article in Canadian journal of kidney health and disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.
- Representation of multimorbidity and frailty in the development and validation of kidney failure prognostic prediction models: a systematic review.BMC medicine · 2024Pooled it
- External validation, recalibration, and clinical utility of the kidney failure risk equation in patients with advanced CKD: a nationwide retrospective cohort analysis in Peru.BMC nephrology · 2025Article
- Early prediction of end-stage kidney disease using electronic health record data: a machine learning approach with a 2-year horizon.JAMIA open · 2024Article
- Article
- Predictive Value of Kidney Failure Risk Equation and Neutrophil Gelatinase-Associated Lipocalin for Chronic Kidney Disease Progression in Chinese Population - A Retrospective Study.International journal of general medicine · 2024Article
- Recalibrating the kidney failure risk equation for a Mediterranean European population: reducing age and sex inequality.Frontiers in medicine · 2024Article
- Clinical Decision Support Tools in the Electronic Medical Record.Kidney international reports · 2024Review
- The kidney failure risk equation predicts kidney failure: Validation in an Australian cohort.Nephrology (Carlton, Vic.) · 2023Article
- Implementing a Formalized Risk-Based Approach to Determine Candidacy for Multidisciplinary CKD Care: A Descriptive Cohort Study.Canadian journal of kidney health and disease · 2023Article
- Age-adapted eGFR thresholds underestimate the risks beyond kidney failure associated with CKD in older populations.Journal of the American Geriatrics Society · 2022Article
- Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease.Clinical kidney journal · 2022Review
- Assessment of Cystatin C Level for Risk Stratification in Adults With Chronic Kidney Disease.JAMA network open · 2022Article
- Independent External Validation and Comparison of Death and Kidney Replacement Therapy Prediction Models in Advanced CKD.Kidney medicine · 2022Article
- Article
- Bridging Gaps in Diabetic Nephropathy Care: A Narrative Review Guided by the Lived Experiences of Patient Partners.Canadian journal of kidney health and disease · 2022Review
- Impacting Management of Chronic Kidney Disease Through Primary Care Practice Audits: A Quality Improvement Study.Canadian journal of kidney health and disease · 2022Article
- The Effect of Age on Performance of the Kidney Failure Risk Equation in Advanced CKD.Kidney international reports · 2021Article
- Is It Time for Machine Learning Algorithms to Predict the Risk of Kidney Failure in Patients with Chronic Kidney Disease?Journal of clinical medicine · 2021Article
- A novel drug response score more accurately predicts renoprotective drug effects than existing renal risk scores.Therapeutic advances in endocrinology and metabolism · 2021Article
- The Impact of a New Triage and Booking System on Renal Clinic Wait Times.Canadian journal of kidney health and disease · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with chronic kidney disease (CKD) are at risk to progress to kidney failure. We previously developed the Kidney Failure Risk Equation (KFRE) to predict progression to kidney failure in patients referred to nephrologists.
objectiveThe objective of this study was to determine the ability of the KFRE to discriminate which patients will progress to kidney failure in an unreferred population.
designA retrospective cohort study was conducted using administrative databases.
settingThis study took place in Manitoba, Canada. MEASUREMENTS: Age, sex, estimated glomerular filtration rate (eGFR), and urine albumin-to-creatinine ratio (ACR) were measured.
methodsWe included patients from the Diagnostic Services of Manitoba database with an eGFR <60 mL/min/1.73 m
resultsOf 1512 included patients, 151 developed kidney failure over the 5-year follow-up period. The 4-variable KFRE showed a superior prognostic discrimination compared with eGFR alone (area under the receiver operating characteristic curve [AUROC] values, 0.90 [95% confidence interval {CI}: 0.88-0.92] for KFRE vs 0.78 [95% CI: 0.74-0.83] for eGFR). At a 3% threshold over 5 years, the KFRE had a sensitivity of 97% and a specificity of 62%. At 10% risk, sensitivity was 86%, and specificity was 80%. LIMITATIONS: Only 11.7% of stage 3-5 CKD patients had simultaneous ACR measurement. The KFRE does not account for other indications for referral such as suspected glomerulonephritis, polycystic kidney disease, and recurrent stone disease.
conclusionsThe KFRE has been validated in a population with a demographic and referral profile heretofore untested and performs well at predicting 5-year risk of kidney failure in a population-based sample of Manitobans with CKD stages 3 to 5. Thresholds of 3% and 10% over 5 years are sensitive, specific, and can be used in clinical decision making. Further testing of the 4-variable KFRE and these thresholds in clinical practice should be considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.